Abstract
Background/Aims
There are few data supporting the diagnostic yield of brush cytology depending on the order of cytologic preparation method or the location or shape of tumors in biliary strictures. We investigated diagnostic yields and variations in brush cytology with direct smear and cell-block preparations according to sampling preparation sequence and tumor location and shape in biliary strictures.
Methods
Patients who had undergone ERCP with tissue sampling between August 2009 and April 2013 were analyzed retrospectively. Group A was examined using brush cytology with direct smear followed by cell-block with or without biopsy, while the reverse order was performed for group B.
Results
Among 138 enrolled patients, 92 patients (A: 36, B: 56) underwent both brush cytology with direct smear and cell-block preparations. No differences in sensitivity, specificity, or accuracy were observed according to the sampling preparation method and the location or shape of tumors in biliary strictures. The cellularity observed from brush cytology with direct smear was better than that from cell-block according to the location of the tumor (p<0.01). The diagnostic yield was increased in both groups with addition of an endobiliary biopsy.
References
1. Elek G, Gyökeres T, Schäfer E, Burai M, Pintér F, Pap A. Early diagnosis of pancreatobiliary duct malignancies by brush cytology and biopsy. Pathol Oncol Res. 2005; 11:145–155.
2. Asioli S, Accinelli G, Pacchioni D, Bussolati G. Diagnosis of biliary tract lesions by histological sectioning of brush bristles as alternative to cytological smearing. Am J Gastroenterol. 2008; 103:1274–1281.
3. Noda Y, Fujita N, Kobayashi G, et al. Prospective randomized controlled study comparing cell block method and conventional smear method for bile cytology. Dig Endosc. 2013; 25:444–452.
4. Kurzawinski T, Deery A, Davidson BR. Diagnostic value of cytology for biliary stricture. Br J Surg. 1993; 80:414–421.
5. Kitajima Y, Ohara H, Nakazawa T, et al. Usefulness of transpapillary bile duct brushing cytology and forceps biopsy for improved diagnosis in patients with biliary strictures. J Gastroenterol Hepatol. 2007; 22:1615–1620.
6. De Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). Gastrointest Endosc. 2002; 56:552–561.
7. de Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc. 2002; 56:720–730.
8. Dumonceau JM. Sampling at ERCP for cyto- and histopathologicical examination. Gastrointest Endosc Clin N Am. 2012; 22:461–477.
9. Mutignani M, Galasso D, Familiari P, et al. Comparison of standard and jumbo endobiliary biopsy for histological diagnosis of hilar biliary strictures: interim report of a prospective randomized trial. Gastrointest Endosc. 2008; 67:AB169.
10. Tamada K, Satoh Y, Tomiyama T, et al. Multiple bile duct biopsies using a sheath with a side port: usefulness of intraductal sonography. AJR Am J Roentgenol. 2001; 176:797–802.
11. Osnes M, Serck-Hanssen A, Myren J. Endoscopic retrograde brush cytology (ERBC) of the biliary and pancreatic ducts. Scand J Gastroenterol. 1975; 10:829–831.
12. Weber A, von Weyhern C, Fend F, et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J Gastroenterol. 2008; 14:1097–1101.
13. Logrono R, Kurtycz DF, Molina CP, Trivedi VA, Wong JY, Block KP. Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures: the experience at 2 university hospitals. Arch Pathol Lab Med. 2000; 124:387–392.
14. Nathan NA, Narayan E, Smith MM, Horn MJ. Cell block cytology. Improved preparation and its efficacy in diagnostic cytology. Am J Clin Pathol. 2000; 114:599–606.
15. de Bellis M, Fogel EL, Sherman S, et al. Influence of stricture dilation and repeat brushing on the cancer detection rate of brush cytology in the evaluation of malignant biliary obstruction. Gastrointest Endosc. 2003; 58:176–182.
16. Kawada N, Uehara H, Katayama K, et al. Combined brush cytology and stent placement in a single session for presumed malignant biliary stricture. J Gastroenterol Hepatol. 2011; 26:1247–1251.
17. Dumonceau JM, Macias Gomez C, Casco C, et al. Grasp or brush for biliary sampling at endoscopic retrograde cholangiography? A blinded randomized controlled trial. Am J Gastroenterol. 2008; 103:333–340.
Table 1.
Clinical characteristics | Value |
---|---|
Patient | 138 (100) |
Male/female | 83 (60.1)/55 (39.9) |
Age (yr) | 67.9±11.7 |
Clinical diagnosis | |
Malignant | 113 (81.8) |
Cholangiocarcinoma | 81 (58.6) |
Pancreatic cancer | 24 (17.3) |
Gallbladder cancer | 3 (2.1) |
Hepatocellular carcinoma | 2 (1.4) |
Othersa | 3 (2.1) |
Benign | 25 (18.1) |
Location of lesion (malignant/benign) | |
Intrahepatic | 9 (7.9)/4 (16.0) |
Perihilar | 40 (35.3)/1 (4.0) |
Extrahepatic | 62 (54.8)/17 (68.0) |
Pancreatic duct | 2 (1.7)/3 (12.0) |
Cholangiographic appearance | |
Protuberant (nodular) | 16 (20.2)/4 (5.0) |
Papillary protuberant | 6 (7.5)/0 (0) |
Sclerosed | 29 (36.7)/11 (13.9) |
Constricted | 11 (13.9)/2 (2.5) |
Laboratory finding | |
ALP (IU/L) | 407.0±317.7 |
Total bilirubin (mg/dL) | 9.2±9.46 |
CA 19–9 (U/mL) | 1,499.3±4,895 |
CEA (ng/mL) | 13.6±77.9 |
Table 2.
Subgroup characteristics | Group A | Group B | p-value |
---|---|---|---|
Patient | 36 (100) | 56 (100) | |
Male/female | 21 (58.3)/15 (41.6) | 30 (53.5)/26 (46.4) | 0.654 |
Age (yr) | 66.5±12.6 | 71.6±10.2 | 0.048 |
Clinical diagnosis | |||
Malignant/benign | 31 (86.1)/5 (13.8) | 46 (82.1)/10 (17.8) | 0.615 |
Malignant | 31 (100) | 46 (100) | |
Cholangiocarcinoma | 23 (74.1) | 30 (65.2) | |
Pancreatic cancer | 4 (12.9) | 14 (30.4) | |
GB cancer | 1 (3.2) | 2 (4.3) | |
Othersa | 3 (9.6) | − | |
Location of lesion | − | ||
Intrahepatic | 4 (11.1) | 5 (8.9) | |
Perihilar | 11 (30.5) | 20 (35.7) | |
Extrahepatic | 19 (52.7) | 28 (50.0) | |
Pancreatic duct | 2 (5.5) | 3 (5.3) | |
Cholangiographic appearance | − | ||
Protuberant (nodular) | 5 (13.8) | 10 (27.7) | |
Papillary protuberant | − | 3 (5.3) | |
Sclerosed | 25 (69.4) | 39 (69.6) | |
Constricted | 6 (16.6) | 4 (7.1) | |
Laboratory finding | |||
ALP (IU/L) | 359.0±329.4 | 455.0±319.0 | 0.169 |
Total bilirubin (mg/dL) | 7.6±8.9 | 9.7±9.2 | 0.265 |
CA 19–9 (U/mL) | 1,763±5,313 | 2,306±6,329 | 0.675 |
CEA (ng/mL) | 30.6±153.1 | 10.8±18.98 | 0.459 |
Table 3.
Variable | Endobiliary forceps biopsya | Brush cytology | |
---|---|---|---|
Direct smearb | Cell-blockc | ||
Sensitivity | 32/66 (48.4) | 59/97 (60.8) | 35/62 (56.4) |
Specificity | 11/12 (91.6) | 20/20 (100) | 8/9 (88.8) |
PPV | 32/33 (96.9) | 59/59 (100) | 35/36 (97.2) |
NPV | 11/45 (24.4) | 20/58 (34.4) | 8/35 (22.8) |
Accuracy | 43/78 (55.1) | 79/117 (67.5) | 43/71 (60.5) |
Table 4.
Variable | Both techniquesa | Triple techniquesb | ||||
---|---|---|---|---|---|---|
Group Ac | Group Bd | p-value | Group A | Group B | p-value | |
Sensitivity | 18/31 (58.0) | 30/46 (65.2) | 0.525 | 10/13 (76.9) | 18/29 (62.0) | 0.485 |
Specificity | 5/5 (100) | 9/10 (90.0) | >0.999 | 1/1 (100) | 3/3 (100) | − |
PPV | 18/18 (100) | 30/31 (96.7) | >0.999 | 10/10 (100) | 18/18 (100) | − |
NPV | 5/18 (27.7) | 9/25 (36.0) | 0.570 | 1/4 (25.0) | 3/14 (21.4) | >0.999 |
Accuracy | 23/36 (63.8) | 39/56 (69.6) | 0.566 | 11/14 (78.5) | 21/32 (68.7) | >0.999 |